Conferences
ASCO GU 2024: Discussant: Androgen Deprivation & Radiation Therapy: Going Further, Together
January 26, 2024
ASCO GU 2024: Discussant: Unlocking Combination Therapy for mCRPC
January 26, 2024
ASCO GU 2024: Effect of Urinary Stagnation in the Prostatic Urethra on Generating False-Positive Midline Lesions on 18F-DCFPyL PSMA PET/CT
January 25, 2024
ASCO GU 2024: Renaming Gleason 3+3 (Grade Group 1): Against
January 25, 2024
ASCO GU 2024: Public Health Would Dramatically Improve if Gleason 6 (Grade Group 1) Weren’t Called Cancer
January 25, 2024
ASCO GU 2024: Patient-Provider Rurality and Outcomes in Older Men with Prostate Cancer
January 25, 2024
ASCO GU 2024: Systemic Treatment of High-Risk Biochemical Recurrence
January 25, 2024
ASCO GU 2024: Prostate Cancer Foundation (PCF) Screening Guidelines for Prostate Cancer in Black Men in the United States
January 25, 2024
ASCO GU 2024: Is There a Role for Stereotactic Radiotherapy in Selected Patients With Metastatic Castrate-Resistant Prostate Cancer?
January 25, 2024
ASCO GU 2024: Barriers and Facilitators to First-Line Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer: The IMPLEMENT Study
January 25, 2024